Document:

Exhibit 10.01

 

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (this “Agreement”)
is made and entered into as of this 1st day of April, 2020 by and between Seneca Biopharma, Inc., a Delaware corporation
(the “Company”), and Dane Saglio (the “Employee”).

 

WITNESSETH:

 

WHEREAS, the Company desires to employ
Employee as its Chief Financial Officer and Employee desires to accept such employment; and

 

WHEREAS, the Company desires to enter
into this Agreement regarding the terms of Employee’s employment, and Employee desires to enter into this Agreement and to
accept the terms and provisions of such employment, as embodied in this Agreement.

 

Section 1. Definitions.

 

(a)        
“Accelerated Equity Benefit” shall mean, as applicable: (i) the continued vesting of any outstanding stock options
or other equity awards with time-based vesting during the period ending on the end of the applicable Severance Term, provided,
however, that for avoidance of doubt, any stock option or other equity award that includes both a performance-based vesting condition
(which would include the achievement of a certain stock price or milestone) and a time-based vesting provision, no acceleration
shall be provided unless such performance-based vesting condition has been satisfied as of the Date of Termination; or (ii) in
the event of a Change of Control, the full vesting of all of Employee’s outstanding stock options or other equity awards
as of the Date of Termination. Additionally, for purpose of determining the ability of Employee to exercise any vested outstanding
stock options or other equity awards, Employee will be deemed to have ceased being a “Service Provider,” on the last
day of the applicable Severance Term.

 

(b)       
“Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary through the Date of Termination,
(ii) all bonuses that have been awarded but remain unpaid as of the Date of Termination, (iii) any unpaid or unreimbursed
expenses incurred in accordance with Section 6 hereof, (iv) any accrued but unpaid benefits provided under the Company’s
employee benefit plans, subject to and in accordance with the terms of those plans, (v) any accrued but unpaid rights to indemnification
by virtue of the Employee’s position as an officer or director of the Company or its subsidiaries and the benefits under
any directors’ and officers’ liability insurance policy maintained by the Company, in accordance with its terms thereof,
and (vi) any accrued but unused vacation time through the Date of Termination.

 

(c)        
“Annual Equity Grant” shall have the meaning ascribed to in Section 4(c) hereof.

 

(d)       
“Base Salary” shall mean the salary provided for in Section 4(a) hereof.

 

(e)        
“Beneficial Ownership” shall have the meaning set forth in in Rule 13d-3 of the Exchange Act; provided,
however, that, notwithstanding anything in Rule 13d-3 of the Exchange Act to the contrary, for purposes of Section 1(k)(1)
below, a Person shall not be deemed to have Beneficial Ownership of any shares of Common Stock underlying any Common Stock Equivalents
unless and until such Person actually acquires such shares of Common Stock upon exercise, exchange or conversion of such Common
Stock Equivalents.

 

    1

     

    

(f)        
“Board” shall mean the Board of Directors of the Company or any committee thereof.

 

(g)       
“Common Stock” shall mean the Company’s common stock, $0.01 par value per share.

 

(h)       
“Common Stock Equivalents” shall mean any securities of the kind which would entitle the holder thereof to acquire
at any time, Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

(i)         
“Confidentiality Agreement” shall mean the Company’s Confidential Information and Invention Assignment
Agreement attached hereto as Exhibit B.

 

(j)        “Cause”
shall mean (i) Employee’s material failure (except where due to a Disability) or refusal to meet the reasonable, legitimate
performance criteria of Employee’s position; (ii) any intentional or grossly negligent act of Employee that has, or
could reasonably be expected to have, the effect of injuring the business of the Company or its subsidiaries in any material respect;
(iii) Employee’s conviction of, or plea of guilty or no contest to: (x) a felony, (y) any material violation
of federal or state securities laws or (z) any other criminal charge that has, or could be reasonably expected to have, a
material adverse effect on the performance of Employee’s duties to the Company or otherwise result in material injury to
the business of the Company or its subsidiaries; (iv) the commission by Employee of an act of fraud or embezzlement against
the Company or its subsidiaries; (v) any material violation by Employee of the policies of the Company or its subsidiaries,
including but not limited to those relating to sexual harassment or business conduct and those otherwise set forth in the manuals
or statements of policy of the Company or its subsidiaries, and which Employee knows or in the exercise of reasonable diligence
should know will or could result in a material adverse effect on the business or reputation of the Company or its subsidiaries:
or (vi)  Employee’s breach of this Agreement or breach of the Confidentiality Agreement.

 

(k)        “Change
of Control” shall mean the occurrence of any of the following events:

 

(1)       
The acquisition by a Person or its affiliates of ownership of stock of the Company if, immediately after such acquisition, such
Person and its affiliates collectively have Beneficial Ownership of issued and outstanding stock of the Company representing more
than twenty percent (20%) of the total voting power of the issued and outstanding stock of the Company; provided, however, that
for purposes of this subsection (1), the acquisition of stock by a Person from the Company in a transaction or issuance (including
pursuant to equity awards) approved by the Board will not be considered a Change of Control even if, immediately after such acquisition,
such Person and its affiliates collectively have Beneficial Ownership of issued and outstanding stock of the Company representing
more than twenty percent (20%) of the total voting power of the issued and outstanding stock of the Company unless at the time
of such acquisition or at any time within one year following such acquisition, the Company’s Executive Chairman is no longer
deemed a Service Provider to the Company and the change in the Executive Chairman’s status was involuntary and not the result
of a termination due to death or disability, in which case such acquisition shall be treated as a Change of Control for purposes
of this subsection (1) notwithstanding that such acquisition or the transaction that resulted in such acquisition was approved
by the Board; or

 

(2)        If,
during any period of twelve (12) months in which the Company has a class of securities registered pursuant to Section 12 of the
Exchange Act, a change in the composition of the Board occurs as a result of which fewer than a majority of the members of the
Board are Incumbent Directors; or

 

(3)        The
consummation of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would
result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of
the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately
after such merger or consolidation; or

 

    2

     

    

(4)        The
acquisition by a Person or its affiliates (or a series of acquisitions by a Person or its affiliates during the twelve (12) month
period ending on the date of the most recent acquisition by such Person or any of its affiliates) of assets from the Company that
have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the
assets of the Company immediately prior to such acquisition or such series of acquisitions; provided, however, that the foregoing
provisions of this subsection (4) shall not be applicable to a transfer of assets by the Company to an entity, fifty percent (50%)
or more of the total value or voting power of which is owned, directly or indirectly, by the Company. For purposes of this subsection
(4), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined
without regard to any liabilities associated with such assets.

 

For the avoidance of doubt, a transaction will
not constitute a Change of Control for purposes of this Section 1(k) if: (i) its primary purpose is to change the jurisdiction
of the Company’s incorporation, or (ii) its primary purpose is to create a holding company that will be owned in substantially
the same proportions by the persons who held the Company’s securities immediately before such transaction.

 

For purposes of this Section, “affiliate”
will mean, with respect to any specified Person, any other Person that directly or indirectly, through one or more intermediaries,
controls, is controlled by, or is under common control with, such specified Person (“control,” “controlled by”
and “under common control with” will mean the possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of a person, whether through ownership of voting securities, by contact or credit arrangement,
as trustee or executor, or otherwise).

 

(l)       “Code”
shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.

 

(m)        “Date
of Termination” shall mean the date on which Employee’s employment as Chief Financial Officer of the Company terminates
which date shall be the same date as Employee’s “separation from service” from the Company as determined under
Treas. Reg. Section 1.409A-1(h), as uniformly applied by the Company.

 

(n)        “Dilutive
Event” shall mean, except in the case and to the extent of Common Stock issued upon exercise of Excluded Securities,
the issuance by the Company of Common Stock (i) at any time during the Measurement Period (including, without limitation, by virtue
of the exercise, conversion or exchange of any Qualifying Securities at any time on or prior to the end of the applicable Measurement
Period) or (ii) in connection with the exercise, conversion or exchange of any Qualifying Securities at any time after the Measurement
Period.

 

(o)        “Disability”
shall mean any physical or mental disability or infirmity of Employee that prevents the performance of Employee’s duties
for a period of no less than (i) ninety (90) consecutive days or (ii) one hundred twenty (120) non-consecutive
days during any twelve (12) month period provided, however, in the event that the Company temporarily replaces the Employee,
or transfers the Employee’s duties or responsibilities to another individual on account of the Employee's inability to perform
such duties due to a mental or physical incapacity which is, or is reasonably expected to become, a Disability, then the Employee’s
employment shall not be deemed terminated by the Company and the Employee shall not be able to resign with Good Reason as a result
thereof. Any question as to the existence of the Employee’s Disability as to which the Employee and the Company cannot agree
shall be determined in writing by a qualified independent physician mutually acceptable to the Employee or his guardian (which
approval shall not be unreasonably withheld). The determination of Disability made in writing to the Company and the Employee shall
be final and conclusive for all purposes of this Agreement.

 

    3

     

    

(p)        “Effective
Date” shall mean April 1, 2020.

 

(q)       “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(r)        “Excluded
Securities” shall mean stock options exercisable for shares of Common Stock that are granted to officers or employees
(provided that such stock options do not exceed 10% of the Company’s issued and outstanding shares of Common Stock at the
end of the Measurement Period).

 

(s)        “Good
Reason” shall mean (i)(A) a material diminution in Employee’s authority, duties, or responsibilities from
Employee’s authority, duties or responsibilities as of the Effective Date (other than temporarily while the Executive is
physically or mentally incapacitated or as required by applicable law), (B) an adverse change in Employee’s position, or
the authority, duties, or responsibilities of the person or entity to whom Employee reports, or (C) permanent assignment to Employee
of duties not commensurate with his position, (ii) a reduction in Base Salary as set forth in Section 4(a) hereof other
than a general reduction in Base Salary (not to exceed a reduction of 25%) that affects all similarly situated executives in substantially
the same proportions, (iii) any requirement by or directive from the Company, which is not recommended by Employee, that requires
Employee to permanently relocate his principal residence or results in a change in the primary place of the Company’s business
by more than 50 miles from its current location, or (iv) any other material breach of a provision of this Agreement by the
Company (other than a provision that is covered by clause (i), (ii) or (iii) above). Employee acknowledges and agrees
that Employee’s exclusive remedy in the event of any material breach of this Agreement shall be to assert Good Reason pursuant
to the terms and conditions of Section 7(e) hereof. Notwithstanding the foregoing, during the Term, in the event that the
Company reasonably believes that Employee may have engaged in conduct that could constitute Cause hereunder, the Company may, in
its sole and absolute discretion, suspend Employee from performing Employee’s duties hereunder for a period not to exceed
90 days, and in no event shall such suspension constitute an event pursuant to which Employee may terminate employment with Good
Reason or otherwise constitute a breach hereunder; provided, that no such suspension shall alter the Company’s obligations
under this Agreement during such period of suspension.

 

(t)       “Incumbent
Directors” means members of the Board who either (A) are members of the Board as of the date of this Agreement or
(B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent
Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection
with an actual or threatened proxy contest relating to the election of directors to the Company).

 

(u)       “Inducement
Plan” shall have the meaning ascribed to it in Section 4(d) hereof.

 

(v)       “Measurement
Period” shall mean the later of: (i) the nine (9) month period following the Effective Date, or (ii) in the event that
during such nine (9) month period, the Board, authorizes or approves a Dilutive Event or the Company enters into a written agreement
that contemplates effecting a Dilutive Event, then the period of time commencing on the Effective Date and ending upon the occurrence
of such Dilutive Event. Provided however that in the event the Board decides to not consummate the transaction(s) contemplated
in subsection (ii) contained herein, the Measurement Period will be as provided for in subsection (i) contained in this definition.

 

    4

     

    

(w)       “Option
Award” shall have the meaning ascribed to it in Section 4(d) hereof.

 

(x)       “Option
Award Adjustment” shall mean, in the event that the Option Award remains outstanding at the time of a Change of Control
transaction and that, in connection with such Change of Control transaction, any then outstanding Qualifying Securities are entitled
to receive consideration in connection with such Change of Control transaction or are assumed in connection with such Change of
Control transaction, then, any such Qualifying Securities shall be deemed to be exercised, converted or exchanged in full immediately
prior to the closing of such Change of Control transaction, all of the shares of Common Stock underlying such Qualifying Securities
shall be deemed to be issued immediately prior to the closing of such Change of Control Transaction and such deemed issuance of
such shares of Common Stock shall be deemed to be a Dilutive Transaction that will result in an increase in the number of Option
Shares in accordance with the provisions contemplated in Section 4(d).

 

(y)       “Option
Shares” shall mean the shares of Common Stock underlying the Option Award.

 

(z)       “Payment
Date” shall have the meaning ascribed to it in Section 7(h) hereof.

 

(aa)     “Person” shall mean
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind or more than such person
or entity acting as a group.

 

(bb)     “Post-Dilutive Event Common
Shares” shall mean, with respect to a Dilutive Event, the number of shares of Common Stock issued in connection with
such Dilutive Event plus the number of shares of Qualifying Common Stock outstanding immediately before such Dilutive Event.

 

(cc)     “Pre-Dilutive Event Common Shares”
shall mean, with respect to a Dilutive Event, the number of shares of Qualifying Common Stock outstanding immediately prior to
such Dilutive Event.

 

(dd)     “Qualifying Common Stock”
shall mean (i) shares of Common Stock that are issued and outstanding at any time on or prior to the end of the applicable Measurement
Period (including, without limitation, by virtue of the exercise, conversion or exchange of any Qualifying Securities at any time
on or prior to the end of the applicable Measurement Period), plus (ii) any shares of Common Stock that are issued at any time
after the end of the applicable Measurement Period upon the exercise, conversion or exchange of any Qualifying Securities.

 

(ee)     “Qualifying Securities”
shall mean any Common Stock Equivalents that are issued and outstanding at any time on or prior to the end of the applicable Measurement
Period.

 

(ff)     “Release of Claims”
shall mean a release of claims made by the Employee in favor of the Company and its subsidiaries in the form attached hereto as
Exhibit A (with any updates reasonably determined by the Company to be necessary to comply with applicable law) and the
execution of which is a condition precedent to Employee’s eligibility for Severance Benefits and the Accelerated Equity Benefit
in the event his employment is terminated by the Company without Cause or by Employee for Good Reason, as described in Sections
7(d) and 7(e), or in connection with a Change of Control, as described in Section 7(g).

 

    5

     

    

(gg)     “Severance Benefits”
shall mean (i) continued payment of the Base Salary (as in effect immediately prior to termination of Employee’s employment
with the Company and without giving effect to any proration or any reduction to the Base Salary that gives rise to Good Reason)
during the Severance Term, payable in accordance with the Company’s regular payroll practices, (ii) either (x) a lump sum
payment equal to the product of: (A) Employee’s Target Cash Bonus for the year in which the Termination Date occurs, paid
at a rate equivalent to 100% achievement of objectives for such year and (B) a fraction, the numerator of which is the number of
days the Employee was employed by the Company during the year in which the Date of Termination occurs and the denominator of which
is the number of days in such year, which lump sum payment shall be paid on the Payment Date (as defined in Section 7(h), or (y)
in the event of termination of Employee’s employment with the Company in connection with a Change of Control as described
in Section 7(g), Employee’s Target Cash Bonus for the year in which the Termination Date occurs, paid at a rate equivalent
to 100% achievement of objectives for such year, and (iii) if Employee qualifies for and timely elects continued coverage under
the Company’s group medical plan and/or group dental plan pursuant to Section 4980B of the Code (“COBRA”), monthly
payment during the Severance Term of the amount the Company pays on behalf of comparable employees who have elected the same level
of coverage as Employee.

 

(hh)     “Service Provider” shall means
an employee, director or consultant.

 

(ii)       “Severance
Term” shall mean: (i) in the event the Date of Termination occurs after the nine (9) month anniversary of the Effective
Date, (y) the nine (9) month period, which commences on the first day following the Date of Termination by the Company without
Cause or by Employee for Good Reason, or (z) in the event of a Change of Control as described in Section 7(g), the twelve (12)
month period commencing on the first day following the Date of Termination by the Company without Cause or by Employee for Good
Reason, or (ii) in the event the Date of Termination occurs within nine (9) months of the Effective Date, (a) the five (5) month
period, which commences on the first day following the Date of Termination by the Company without Cause or by Employee for Good
Reason, or (b) in the event of a Change of Control as described in Section 7(g), the six (6) month period commencing on the first
day following the Date of Termination by the Company without Cause or by Employee for Good Reason.

 

(jj)     “Target Cash Bonus”
shall have the meaning ascribed to it in Section 4(b) hereof.

 

(kk)     “Term” shall have
the meaning ascribed to it in Section 2 hereof.

 

Section 2. Acceptance and Term.
Commencing on the Effective Date, the Company agrees to employ Employee on an at-will basis (subject to the terms of Sections
7(b), 7(d), 7(e) and 7(g) hereof), and Employee agrees to accept such employment and serve the Company, in accordance with the
terms and conditions set forth herein. The term of employment shall commence on the Effective Date and continue until terminated
by either party at any time, subject to the provisions herein (referred to herein as the “Term”).

 

Section 3. Position, Duties, and Responsibilities; Place
of Performance.

 

(a)        Position,
Duties, and Responsibilities. During the Term, Employee shall be employed and serve as Chief Financial Officer of the Company
(together with such other positions or duties, consistent with Employee’s title, as the Board may reasonably specify from
time to time) and shall have such duties and responsibilities commensurate therewith.

 

    6

     

    

(b)        Performance.
Employee shall devote his full business time, attention, skill, and best efforts to the performance of his duties under this Agreement
and shall not engage in any other occupation during the Term, including, without limitation, any activity that (x) conflicts
with the interests of the Company, (y) interferes with the proper and efficient performance of Employee’s duties for
the Company, or (z) reasonably could interfere with Employee’s exercise of judgment in the Company’s best interests.
Notwithstanding the foregoing, nothing herein shall preclude Employee from: (i) continuing to serve on existing boards of
directors as of the Effective Date until Employee’s current term on those boards expires or (ii) serving, with the prior
consent and approval of the Board, (which shall not be unreasonably withheld or delayed) as a member of no more than two (2) other
boards of directors provided that service on any such board complies with the factors contained in (x), (y) and (z) above
or advisory boards (or their equivalents in the case of a non-corporate entity) of non-competing businesses and charitable organizations;
(iii) engaging in charitable activities and community affairs; and (iv) managing Employee’s personal investments
and affairs; provided, however, that the activities set out in clauses (i), (ii), (iii) and (iv) herein shall
be limited by Employee so as not to interfere in any material respect, individually or in the aggregate, with the performance of
Employee’s duties and responsibilities hereunder, or pose a conflict of interest or violate any provision of this Agreement
with such determinations to be made at the discretion of the Board. Employee represents that he has provided the Company with a
comprehensive list of all outside professional activities with which he is currently involved or reasonably expects to become involved
at the current time. In the event that, during his employment by the Company, the Employee desires to engage in other outside professional
activities, not included on such list, Employee will, prior to engaging in any such activities, first seek written approval from
the Board and such approval shall not be unreasonably withheld.

 

Section 4. Compensation.

 

(a)        Base
Salary. In exchange for Employee’s performance of his duties and responsibilities, Employee initially shall be paid an
annual base salary of $375,000 (“Base Salary”), payable in accordance with the regular payroll practices of
the Company. All payments referenced in this Agreement are on a gross, pre-tax basis and shall be subject to all applicable federal,
state and local withholding, payroll and other taxes.

 

(b)        Target
Cash Bonus. In addition to the Base Salary, Employee will be eligible to earn a discretionary annual target bonus. As of the
Effective Date, Employee’s annual target bonus is up to 40% of his Base Salary, subject to the Board’s (or a committee
thereof) discretion to grant a higher bonus amount (the “Target Cash Bonus”). The Target Cash Bonus amount is
subject to annual review and adjustment (either increase or decrease) as determined by the Board (or a committee thereof). The
actual amount of such bonus, if any, will be determined by the Board (or a committee thereof) based upon Company performance, its
financial condition, Employee’s achievement of performance milestones to be agreed upon by Employee and the Board during
the first quarter of the applicable fiscal year, and any other factors that the Board (or a committee thereof), in its reasonable
good faith discretion, deems appropriate. Employee’s achievement of such milestones, as well as the amount of any bonus,
shall be determined by the Board in its reasonable good faith discretion. Bonuses, if any, shall be paid out no later than March 15
of the year following the applicable bonus year. Except as otherwise provided in Section 7 of this Agreement, Employee must be
employed by the Company at the time the bonus is awarded and through the end of the calendar year in which any bonus may be earned
in order to be eligible for any such payment.

 

    7

     

    

(c)       Annual
Equity Award. In addition to the Base Salary and Target Cash Bonus, Employee will be eligible to receive an annual market-based
equity grant (the “Annual Equity Grant”) issued pursuant to the terms of one of the Company’s equity compensation
plans. The actual amount of such Annual Equity Grant, if any, will be determined by the Board based upon Company performance, its
financial condition (including market value and capitalization), Employee’s achievement of performance milestones and any
other factors that the Board, in its reasonable good faith discretion, deems appropriate. Achievement of such milestones or any
such other factors shall be determined by the Board in its reasonable good faith discretion. In connection with such grants, the
Employee shall enter into one of the Company’s standard equity grant agreements which will incorporate the vesting schedule
and other terms as determined by the Board.

 

(d)        Inducement
Grants. On the Effective Date, as an inducement for Employee’s employment, the Company will grant Employee an option
to purchase 70,710shares of Common Stock, which option shall be granted under the Company’s Inducement Award Stock Option
Plan (or a successor plan, if any) (the “Inducement Plan”) and shall be subject to the terms and conditions
set forth in this Agreement, the Inducement Plan and a stock option agreement to be entered by the Company and the Employee to
evidence such grant, the form of which has been made available to Employee prior to the Effective Date (the “Option Agreement”
and such grant the “Option Award”). In the event of a conflict between the Option Agreement or the Inducement
Plan, on the one hand, and this Agreement, on the other hand, with respect to the Option Award or any of the terms and conditions
thereof, this Agreement shall control. The option subject to the Option Award shall have a term of ten (10) years from the date
of grant and an exercise price equal to the closing trading price of the Common Stock on the Effective Date (or the prior closing
price if the Effective Date is on a day that the trading markets are not open). The Option Award will be subject to vesting as
follows: (i) 1/4 of the Option Award will vest on the Effective Date, and (ii) the balance of the Option Award will vest monthly
over the following thirty six (36) months, provided, however, that Employee must remain continuously employed through the
applicable vesting dates, and the Option Award shall be subject to accelerated vesting under certain circumstances in accordance
with the provisions of Section 7 hereof. The Option Award shall be subject to the terms set forth in the Option Agreement, the
terms of the Inducement Plan, this Section 4(d), Section 7 hereof, and any other restrictions and limitations generally applicable
to Common Stock of the Company or equity awards held by similarly situated Company executives that are imposed by law. Upon the
occurrence of a Dilutive Event, the Option Shares will be increased by such number as required to make the percentage that the
Option Shares (after giving effect to such increase) represent of the Post-Dilutive Event Common Shares equal to the percentage
that the number of Option Shares immediately prior to the Dilutive Event represent of the Pre-Dilutive Event Common Shares. In
addition, the Option Shares may be increased by the Option Award Adjustment, if applicable, in connection with a Change of Control
transaction. Any increase in the number of Option Shares, as contemplated above in this Section 4(d), in connection with the occurrence
of a Dilutive Event or a Change of Control transaction shall occur automatically pursuant to the terms and conditions of the Option
Award as set forth in this Section 4(d) and the Option Agreement without any act or action required to be taken by either the Company
or Employee.

 

(e) Intentionally Omitted

 

(f)       Directors’
and Officers’ Liability Insurance. Employee shall be designated as a “covered person” under the Company’s
Director’s and Officer’s insurance coverage, if any, and shall be covered to the same extent as other directors and
executive officers, including following the termination of Employee’s employment for any reason for the maximum statute of
limitations period which could apply to any claim against Employee which otherwise would be covered by such insurance.

 

(g) Clawback Provisions. Notwithstanding
any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Employee under this
Agreement or any other agreement or arrangement with the Company which is subject to recovery under any law, government regulation,
or stock exchange listing requirement will be subject to such deductions and clawback as may be required to be made pursuant to
such law, government regulation, or stock exchange listing requirement (or any policy adopted by the Company pursuant to any such
law, government regulation or stock exchange listing requirement).

 

    8

     

    

Section 5. Employee Benefits. During
the Term, Employee shall be eligible to participate in health insurance and other benefits provided generally to similarly situated
employees of the Company, subject to the terms and conditions of the applicable benefit plans (which shall govern). In addition
to holidays recognized by the Company, Employee also shall receive four (4) weeks of paid vacation per year, with up to a maximum
of two (2) weeks that can carry over on a yearly basis. Nothing contained herein shall be construed to limit the Company’s
ability to amend, suspend, or terminate any employee benefit plan or policy at any time without providing Employee notice, and
the right to do so is expressly reserved.

 

Section 6.
Reimbursement of Business Expenses. The Company shall pay (or promptly reimburse Employee
in no event later than December 31 of the calendar year following the calendar year in which the expense was incurred) for documented,
out-of-pocket expenses reasonably incurred by Employee in the course of performing his duties and responsibilities hereunder, which
are consistent with the Company’s policies in effect and as amended from time to time, and with respect to business expenses,
subject to the Company’s requirements with respect to documentation and reporting of such expenses, and in accordance with
the rules and regulations of the Internal Revenue Service under the Internal Revenue Code of 1986, as amended (the “Code”)
and in accordance with the Company’s accountable expense reimbursement plan. Such reimbursement payments will be made in
no event later than December 31 of the calendar year following the Effective Date.

  

Section 7. Termination of Employment.

 

(a)        General.
Employee’s employment with the Company shall terminate upon the earliest to occur of: (i) Employee’s death, (ii) a
termination by reason of Employee’s Disability, (iii) a termination by the Company with or without Cause, or (iv) a
termination by Employee with or without Good Reason.

 

(b)        Termination
Due to Death or Disability. Employee’s employment under this Agreement will terminate automatically upon Employee’s
death. The Company also may terminate Employee’s employment immediately upon the occurrence of a Disability, such termination
to be effective upon Employee’s receipt of written notice of such termination. In the event of Employee’s termination
as a result of Employee’s death or Disability, Employee’s or Employee’s estates or beneficiaries, as the case
may be, will be entitled to receive the Accrued Obligations. Employee shall have no further rights to any compensation or any other
benefits under this Agreement.

 

(c)        Termination by
the Company with Cause.

 

(i)        The
Company may terminate Employee’s employment at any time with Cause, effective upon Employee’s receipt of written notice
of such termination; provided, however, that with respect to any Cause termination relying on clause (i), (ii), (v),
or (vi) of the definition of Cause set forth in this Agreement, to the extent that such act or acts or failure or failures
to act are curable, Employee shall be given thirty (30) days’ written notice by the Company of its intention to terminate
his employment with Cause, such notice to state the act or acts or failure or failures that constitute the grounds on which the
proposed termination with Cause is based, and must specify all relevant facts to support that conclusion, and if the circumstances
justifying Cause are susceptible of cure, in the Boar’s reasonable judgement, such termination shall be effective at the
expiration of such thirty (30) day notice period unless Employee has fully cured such act or acts or failure or failures to
act, to the Board’s complete satisfaction, that give rise to Cause during such period.

 

    9

     

    

(ii)        In
the event that the Company terminates Employee’s employment with Cause, Employee shall be entitled only to the Accrued Obligations.
Following such termination of Employee’s employment with Cause, except as set forth in this Section 7(c)(ii), Employee
shall have no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Employee’s
sole and exclusive compensation upon a termination of employment by the Company with Cause, absent a final judgment that the Company
did not have Cause to terminate employment, shall be receipt of the Accrued Obligations.

 

(d)        Termination
by the Company without Cause. The Company may terminate Employee’s employment at any time without Cause, effective upon
Employee’s receipt of written notice of such termination. In the event that Employee’s employment is terminated by
the Company without Cause (other than due to death or Disability) and, with respect to the Severance Benefits and the Accelerated
Equity Benefits, provided that he fully executes and does not revoke an effective Release of Claims as described in Section 7(h),
then, except as otherwise provided in Section 7(g), Employee shall be entitled to:

 

		(i)	the Accrued Obligations;

 

		(ii)	the Severance Benefits; and

 

		(iii)	the Accelerated Equity Benefit.

 

Notwithstanding the foregoing, the Severance Benefits shall immediately
terminate, and the Company shall have no further obligations to Employee with respect thereto, in the event that Employee is found
by a court of competent jurisdiction to have breached this Agreement, any provision of the Confidentiality Agreement or the Release
of Claims. Any such termination of payment or benefits shall have no effect on the Release of Claims or any of Employee’s
post-employment obligations to the Company. Following such termination of Employee’s employment by the Company without Cause,
except as set forth in this Section 7(d) or 7(g), Employee shall have no further rights to any compensation or any other benefits
under this Agreement. For the avoidance of doubt, except as otherwise provided in Section 7(g), Employee’s sole and
exclusive compensation upon a termination of employment by the Company without Cause shall be receipt of (i) the Severance
Benefits and Accelerated Equity Benefits subject to his execution of the Release of Claims, and (ii) the Accrued Obligations.
If the Company makes overpayments of Severance Benefits, Employee promptly shall return any such overpayments to the Company and/or
hereby authorizes deductions from future Severance Benefit amounts so long as such deduction does not violate Section 409A of the
Code.

 

(e)        Termination
by Employee with Good Reason. Employee may terminate his employment with Good Reason by providing the Company at least thirty
(30) days’ written notice setting forth in reasonable specificity, the event that constitutes Good Reason, which written
notice, to be effective, must be provided to the Company on or prior to the later of: (i) within thirty (30) days of the occurrence
of such event or (ii) promptly upon Employee’s actual knowledge of such event. During such notice period, the Company shall
have a cure right (if curable), and if not cured within such period, Employee’s termination will be effective upon the expiration
of such cure period, and Employee shall be entitled to the same payments and benefits as provided in Section 7(d) hereof,
subject to the same conditions on payment and benefits as described in Section 7(d) hereof. Following such termination of
Employee’s employment by Employee with Good Reason, except as set forth in this Section 7(e) or as otherwise provided
in Section 7(g), Employee shall have no further rights to any compensation or any other benefits under this Agreement. For
the avoidance of doubt, except as otherwise provided in Section 7(g), Employee’s sole and exclusive compensation upon
a termination of employment with Good Reason shall be receipt of the same payments and benefits described in Section 7(d) hereof,
subject to the same conditions on payment and benefits as described in Section 7(d).

 

    10

     

    

(f)        Termination
by Employee without Good Reason. Employee may terminate his employment without Good Reason by providing the Company at least
thirty (30) days’ written notice of such termination. In the event of a termination of employment by Employee under
this Section 7(f), Employee shall be entitled only to the Accrued Obligations. In the event of termination of Employee’s
employment under this Section 7(f), the Company may, in its sole and absolute discretion, by written notice accelerate such
date of termination without changing the characterization of such termination as a termination by Employee without Good Reason.
Following such termination of Employee’s employment by Employee without Good Reason, except as set forth in this Section 7(f)
or as otherwise provided in Section 7(g), Employee shall have no further rights to any compensation or any other benefits
under this Agreement. For the avoidance of doubt, Employee’s sole and exclusive compensation upon a termination of employment
by Employee without Good Reason shall be receipt of the Accrued Obligations.

 

(g)        Termination
following a Change of Control. In the event that Employee’s employment is terminated in the three (3) month period
preceding or the twelve (12) month period following a Change of Control: (a) by the Company for any reason other than
as a result of Employee’s death or Disability pursuant to Section 7(b) or Cause as provided in Section 7(c), or (b)
by Employee with Good Reason pursuant to Section 7(e), then Employee shall be entitled to (in lieu of, and not in addition
to, any payments described in Section 7(d) or (e) of this Agreement):

 

		(i)	the Accrued Obligations;

 

		(ii)	the Severance Benefits; and

 

		(iii)	the Accelerated Equity Benefit.

  

Notwithstanding the foregoing, the Severance Benefits shall immediately
terminate, and the Company shall have no further obligations to Employee with respect thereto, in the event that Employee is found
by a court of competent jurisdiction to have breached this Agreement, any provision of the Confidentiality Agreement or the Release
of Claims. Any such termination of payment or benefits shall have no effect on the Release of Claims or any of Employee’s
post-employment obligations to the Company. If the Company makes overpayments of Severance Benefits, Employee promptly shall return
any such overpayments to the Company and/or hereby authorizes deductions from future Severance Benefit amounts.

 

(h)        Release.
Notwithstanding any provision herein to the contrary, the payment of the Severance Benefits and the provision of the Accelerated
Equity Benefit, pursuant to subsection (b), (d), (e) or (g) of this Section 7, shall be conditioned upon Employee’s
execution, delivery to the Company, and non-revocation of the Release of Claims (and the expiration of any revocation period contained
in such Release of Claims) in accordance with the time limits set forth therein (and, in all events, within sixty (60) days
following the Date of Termination); provided, that, in the case of Employee’s death or Disability, such actions shall be
taken by a representative with authority to bind Employee or, if applicable, his estate. If Employee or his representative fails
to execute the Release of Claims in such a timely manner, or timely revokes Employee’s acceptance of such release following
its execution, Employee and his estate or beneficiaries shall not be entitled to any of the Severance Benefits or the Accelerated
Equity Benefit. Payment of the Severance Benefits will commence (or, at the election of the Company, may be paid in a lump-sum
cash payment rather than in installments during the Severance Term) on the first regular Company payday that is at least five (5) business
days following the date the Company receives a timely, effective and non-revocable Release of Claims (the “Payment Date”);
provided, however, that the first payment will be retroactive to the day immediately following the Date of Termination. Payment
of the bonus contained in the Severance Benefits defined in Section 1(gg) will also be made on the Payment Date. Notwithstanding
the foregoing, to the extent that any portion of the Severance Benefits or the bonus contained in the Severance Benefits defined
in Section 1(gg) constitutes “non-qualified deferred compensation” subject to Section 409A of the Code, any payment
of such portion scheduled to occur prior to the sixtieth (60th) day following the date of Employee’s termination of
employment hereunder, but for the condition on executing the Release of Claims as set forth herein, shall not be made until the
first regularly scheduled payroll date following such sixtieth (60th) day unless otherwise permitted by Section 409A of the
Code, after which any remaining such benefits shall thereafter be provided to Employee according to the applicable schedule set
forth herein. If the sixty (60) day period following Employee’s separation from service begins in one calendar year and ends
in a second calendar year (a “Crossover 60-Day Period”), and if there are any payments due to Employee that are: (i)
conditioned on Employee signing and not revoking a release of claims and (ii) otherwise due to be paid during the portion of, the
Crossover 60-Day Period that falls within the first year, then such payments will be delayed and paid in a lump sum during the
portion of the Crossover 60-Day Period that falls within the second year.

 

    11

     

    

Section 8. Confidentiality Agreement; Cooperation.

 

(a)        Confidentiality
Agreement. As a condition of Employee’s employment with the Company under the terms of this Agreement, Employee has executed
and delivered to the Company a Confidentiality Agreement. The parties hereto acknowledge and agree that this Agreement and the
Confidentiality Agreement shall be considered separate contracts. In addition, Employee represents and warrants that he shall be
able to and will perform the duties of this position without utilizing any confidential and/or proprietary information that Employee
may have obtained in connection with employment with any prior employer, and that he shall not (i) disclose any such information
to the Company, or (ii) induce any Company employee to use any such information, in either case in violation of any confidentiality
obligation, whether by agreement or otherwise.

 

(b)        Litigation
and Regulatory Cooperation. During and after Employee’s employment, Employee shall cooperate fully with the Company in
the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf
of the Company which relate to events or occurrences that transpired while the Company employed Employee, provided, that the Employee
will not have an obligation under this paragraph with respect to any claim in which the Employee has filed directly against the
Company or related persons or entities or if such cooperation would be materially adverse to his own legal interests. The Employee’s
full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel
to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times. During and after
Employee’s employment, Employee also shall cooperate fully with the Company in connection with any investigation or review
of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that transpired
while Employee was employed by the Company, provided Employee will not have any obligation under this paragraph with respect to
any claim in which Employee has filed directly against the Company or related persons or entities. The Company shall reimburse
Employee for any reasonable and documented out-of-pocket expenses incurred in connection with Employee’s performance of obligations
pursuant to this Section 8(b) In the event that Employee has ceased to be employed by the Company prior to the performance
of the obligation pursuant to this Section 10(b), the Company shall compensate Employee at a rate of $250 per hour for all reasonable
documented time.

 

    12

     

    

Section 9. Taxes. 

 

The Company may withhold from any payments
made under this Agreement all applicable taxes, including but not limited to income, employment, and social insurance taxes, as
shall be required by law. Employee acknowledges and represents that the Company has not provided any tax advice to him in connection
with this Agreement and that Employee has been advised by the Company to seek tax advice from Employee’s own tax advisors
regarding this Agreement and payments that may be made to him pursuant to this Agreement, including specifically, the application
of the provisions of Section 409A of the Code to such payments. The Company shall have no liability to Employee or to any
other person if any of the provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A
but that do not satisfy an exemption from, or the conditions of, that section, except in the event of the Company’s or its
subsidiaries’ gross negligence or bad faith.

 

Section 10. Additional Section 409A
Provisions. 

 

Notwithstanding any provision in this Agreement
to the contrary:

 

(a)        Payments
to be made under this Agreement due to a termination of employment may be made only after a “separation from service”
as defined by Section 409A. If at the time of the Employee’s separation from service within the meaning of Section 409A
of the Code, the Company determines that the Employee is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i)
of the Code, then to the extent any payment or benefit that the Employee becomes entitled to under this Agreement on account of
the Employee’s separation from service is “non-qualified deferred compensation” subject to Section 409A
of the Code and not otherwise exempt, such payment shall not be payable and such benefit shall not be provided until the date that
is the earlier of (i) six months and one day after the Employee’s separation from service, or (ii) the Employee’s
death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up
payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision,
and the balance of the installments shall be payable in accordance with their original schedule.

 

(b)        Each
payment in a series of payments hereunder shall be deemed to be a separate and distinct payment for purposes of Section 409A
of the Code. Neither the Company nor Employee shall have the right to accelerate or defer the delivery of any such payments except
to the extent specifically permitted or required by Section 409A.

 

(c)        To
the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified
deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement or payment
shall be made by the Company no later than the last day of the taxable year following the taxable year in which such expense was
incurred by Employee, (ii) the right to reimbursement, payment or in-kind benefits shall not be subject to liquidation or
exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement, payment or in-kind benefits provided
during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other
taxable year; provided , that the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement
covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement
is in effect.

 

    13

     

    

(d)        To
the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation”
under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Employee’s termination
of employment, then such payments or benefits shall be payable only upon the Employee’s “separation from service.”
The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions
set forth in Treasury Regulation Section 1.409A-1(h).

 

(e)        The
parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in
such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may
be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code
and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost
to either party. While the payments and benefits provided hereunder are intended to be structured in a manner to avoid the implication
of any penalty taxes under Section 409A of the Code, in no event whatsoever shall the Company or any of its subsidiaries be
liable for any additional tax, interest, or penalties that may be imposed on Employee as a result of Section 409A of the Code
or any damages for failing to comply with Section 409A of the Code (other than for withholding obligations or other obligations
applicable to employers, if any, under Section 409A of the Code) , except in the event of the Company’s or its subsidiaries’
gross negligence or bad faith.

 

Section 11. Indemnification. On the Effective Date,
Employee and Company will enter into the Company’s standard Indemnification Agreement.

 

Section 12.Additional Section 280G Provisions. Notwithstanding
any provision in this Agreement to the contrary:

 

(a)        If
any of the payments or benefits received or to be received by Employee (including, without limitation, any payment or benefits
received in connection with a Sale Event, Change of Control, or Employee’s termination of employment, whether pursuant to
the terms of this Agreement or any other plan, arrangement or agreement, or otherwise) (all such payments collectively referred
to herein as the “280G Payments”) constitute “parachute payments” within the meaning of Section 280G of
the Code and would, but for this Section 11(a), be subject to the excise tax imposed under Section 4999 of the Code (the “Excise
Tax”), then prior to making the 280G Payments, a calculation shall be made comparing (i) the Net Benefit (as defined below)
to Employee of the 280G Payments after payment of the Excise Tax to (ii) the Net Benefit to Employee if the 280G Payments are limited
to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under clause (i) above is less
than the amount under clause (ii) above will the 280G Payments be reduced to the minimum extent necessary to ensure that no portion
of the 280G Payments is subject to the Excise Tax. “Net Benefit” shall mean the present value of the 280G Payments
net of all federal, state, local, foreign income, employment, and excise taxes. Any reduction made pursuant to this Section 11(a)
shall be made in a manner determined by the Company that is consistent with the requirements of Section 409A of the Code.

 

(b)        All
calculations and determinations under this Section 11 shall be made by an independent accounting firm or independent tax counsel
appointed by the Company (the “Tax Counsel”) whose determinations shall be conclusive and binding on the Company and
the Executive for all purposes. The Company shall bear all costs the Tax Counsel may incur in connection with its services.

 

    14

     

    

Section 13. Successors and Assigns.

 

(a)        The
Company. Except with respect to an assignment of this Agreement to a successor or affiliated entity, this Agreement may not
be assigned without Employee’s prior written consent.

 

(b)        Employee.
Employee’s rights and obligations under this Agreement shall not be transferable by Employee by assignment or otherwise,
without the prior written consent of the Company; provided, however, that if Employee shall die, all cash amounts
then payable to Employee hereunder shall be paid in accordance with the terms of this Agreement to Employee’s devisee, legatee,
or other designee, or if there be no such designee, to Employee’s estate.

 

Section 14. Waiver and Amendments.
Any waiver, alteration, amendment, or modification of any of the terms of this Agreement shall be valid only if made in writing
and signed by each of the parties hereto; provided, however, that any such waiver, alteration, amendment, or modification
must be consented to on the Company’s behalf by the Board. No waiver by either of the parties hereto of their rights hereunder
shall be deemed to constitute a waiver with respect to any subsequent occurrences or transactions hereunder unless such waiver
specifically states that it is to be construed as a continuing waiver.

 

Section 15. Severability. If
any covenants or such other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a
court of competent jurisdiction, (a) the remaining terms and provisions hereof shall be unimpaired, and (b) the invalid
or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that
comes closest to expressing the intention of the invalid or unenforceable term or provision hereof.

 

Section 16. Governing Law and Jurisdiction.
This is a Maryland contract and shall be construed under and be governed in all respects by the laws of Maryland without giving
effect to the conflict of laws principles of such state. To the extent that any court action is initiated to enforce this Agreement,
the parties hereby consent to the non-exclusive jurisdiction of the state and federal courts of Maryland. Accordingly, with respect
to any such court action, each of the Company and Employee hereby (a) submits to the personal jurisdiction of such courts;
(b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court,
or otherwise) with respect to personal jurisdiction or service of process.

 

Section 17.  Notices. 

 

(a)        Place
of Delivery. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or
delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice
mailed or delivered (electronic delivery is acceptable) to the other party as herein provided; provided, that unless and
until some other address be so designated, all notices and communications by Employee to the Company shall be mailed or delivered
to the Company at its principal executive office, and all notices and communications by the Company to Employee may be given to
Employee personally or may be mailed to Employee at Employee’s last known address, as reflected in the Company’s records.

 

(b)        Date
of Delivery. Any notice so addressed shall be deemed to be given or received (i) if delivered by hand, on the date of
such delivery, (ii) if mailed by courier or by overnight mail or electronic mail, on the first business day following the
date of such mailing, and (iii) if mailed by registered or certified mail, on the third business day after the date of such
mailing.

 

    15

     

    

Section 18.  Section Headings.
The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to
constitute a part thereof or affect the meaning or interpretation of this Agreement or of any term or provision hereof.

 

Section 19.  Entire Agreement.
This Agreement, together with Release of Claims, Confidentiality Agreement, the Indemnification Agreement, the Inducement Plan,
and any stock option agreement entered into between the Company and Employee thereunder, constitute the entire understanding and
agreement of the parties hereto regarding the employment of Employee. This Agreement supersedes all prior negotiations, discussions,
correspondence, communications, understandings, and agreements between the parties (including without limitation that any term
sheet or offer letter that may have been given to Employee) relating to the subject matter of this Agreement.

 

Section 20.  Survival of Operative
Sections. Upon any termination of Employee’s employment, the provisions of Section 6 through Section 22 of this
Agreement (together with any related definitions set forth in Section 1 hereof) shall survive to the extent necessary to give
effect to the provisions thereof.

 

Section 21.  Counterparts. This
Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together
shall constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.

 

Section 22.  Gender Neutral. Wherever
used herein, a pronoun in the masculine gender shall be considered as including the feminine gender unless the context clearly
indicates otherwise.

 

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

 

 

    16

     

    

[SIGNATURE PAGE TO EMPLOYMENT AGREEMENT]

 

 

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first
above written.

 

 

 

SENECA BIOPHARMA, INC.

 

 

__________________________ 

By: 

Title: 

 

 

 

 

 

 

 

EMPLOYEE

 

 

 

_________________________ 

By: 

 

 

 

    17

     

    

EXHIBIT A

 

General Release and Waiver of Claims

 

In exchange for the severance benefits to be
provided to me under the Employment Agreement between me and Seneca Biopharma, Inc. (the “Company”), dated as of April
1, 2020, (the “Employment Agreement”), to which I would not otherwise be entitled, on my own behalf and that of my
heirs, executors, administrators, beneficiaries, personal representatives and assigns, I agree that this General Release and Waiver
of Claims (the “Release of Claims”) shall be in complete and final settlement of any and all causes of action, rights
and claims, whether known or unknown, accrued or unaccrued, contingent or otherwise, that I have had in the past, now have, or
might now have, in any way related to, connected with or arising out of my employment or its termination, under the Employment
Agreement, or pursuant to Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination
in Employment Act, as amended by the Older Workers Benefit Protection Act, the Worker Adjustment and Retraining Notification Act,
the Employee Retirement Income Security Act, the wage and hour, wage payment and fair employment practices laws and statutes of
the State of Maryland (each as amended from time to time), and/or any other federal, state or local law, regulation or other requirement
(collectively, the “ Claims ”), and I hereby release and forever discharge the Company, its subsidiaries and
all of their respective past, present and future directors, shareholders, officers, members, managers, general and limited partners,
employees, employee benefit plans, administrators, trustees, agents, representatives, successors and assigns, and all others connected
with any of them, both individually and in their official capacities, from, and I hereby waive, any and all such Claims. This release
shall not apply to (a) any claims that arise after I sign this Release of Claims, including my right to enforce the terms
of this Release of Claims, the Employment Agreement, the Confidentiality Agreement, the Inducement Plan, the Option Agreement and
any other contract between me and the Company; (b) any claims that may not be waived pursuant to applicable law; (c) any
right to indemnification that I may have under the certificate of incorporation or by-laws of the Company, and any Indemnification
Agreement between me and the Company or any insurance policies maintained by the Company; or (d) any right to receive any
vested benefits under the terms of any employee benefit plans and my award agreements thereunder.

 

Nothing contained in this Release of Claims shall be construed to
prohibit me from filing a charge with or participating in any investigation or proceeding conducted by the federal Equal Employment
Opportunity Commission or a comparable state or local agency, provided, however, that I hereby agree to waive my right to recover
monetary damages or other individual relief in any charge, complaint or lawsuit filed by me or by anyone else on my behalf.

 

In signing this Release of Claims, I acknowledge my understanding
that I may consider the terms of this Release of Claims for up to [twenty-one (21)/forty-five (45)]1 days from the
date I receive it and that I may not sign this Release of Claims until after the date my employment with the Company terminates.
I also acknowledge that I am hereby advised by the Company to seek the advice of an attorney prior to signing this Release of
Claims; that I have had sufficient time to consider this Release of Claims and to consult with an attorney, if I wished to do
so, or to consult with any other person of my choosing before signing; and that I am signing this Release of Claims voluntarily
and with a full understanding of its terms.

 

I further acknowledge that, in signing this Release of Claims, I
have not relied on any promises or representations, express or implied, that are not set forth expressly in the Release of Claims.
I understand that I may revoke this Release of Claims at any time within seven (7) days of the date of my signing by written
notice to the Chairman of the Company’s Board of Directors and that this Release of Claims will take effect only upon the
expiration of such seven-day revocation period and only if I have not timely revoked it.

 

_________________________________

1 To be determined by the Company at the time of termination.

 

    18

     

    

Intending to be legally bound, I have signed this Release of Claims as of the date written
below.

 

 

 

Signature ___________________________

 

Name ______________________________

 

Date Signed _________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    19

     

    

EXHIBIT B

 

Confidential Information and Invention Assignment AgreementExhibit 10.02

 

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (this “Agreement”)
is made and entered into as of this 1st day of April, 2020 by and between Seneca Biopharma, Inc., a Delaware corporation
(the “Company”), and Matthew W. Kalnik (the “Employee”).

 

WITNESSETH:

 

WHEREAS, the Company desires to employ
Employee as its President and Chief Operating Officer and Employee desires to accept such employment; and

 

WHEREAS, the Company desires to enter
into this Agreement regarding the terms of Employee’s employment, and Employee desires to enter into this Agreement and to
accept the terms and provisions of such employment, as embodied in this Agreement.

 

Section 1. Definitions.

 

(a)        
“Accelerated Equity Benefit” shall mean, as applicable: (i) the continued vesting of any outstanding stock options
or other equity awards with time-based vesting during the period ending on the earlier of (x) the expiration of the term of the
respective stock option or other equity award (without giving effect to any provision of any equity incentive or stock option plan
or award agreement applicable to any such stock option or other equity award that provides for any early termination or forfeiture
of any such stock options or other equity awards by virtue of any termination of employment or other service of Employee with the
Company) or (y) the end of the applicable Severance Term, provided, however, that for avoidance of doubt, any stock option or other
equity award that includes both a performance-based vesting condition (which would include the achievement of a certain stock price
or milestone) and a time-based vesting provision, no acceleration shall be provided unless such performance-based vesting condition
has been satisfied as of the Date of Termination; or (ii) in the event of a Change of Control, the full vesting of all of Employee’s
outstanding stock options or other equity awards as of the Date of Termination. Additionally, for purpose of determining the ability
of Employee to exercise any vested outstanding stock options or other equity awards, Employee will be deemed to have ceased being
a Service Provider on the last day of the applicable Severance Term.

 

(b)       
“Accrued Obligations” shall mean (i) all accrued but unpaid Base Salary through the Date of Termination,
(ii) all bonuses that have been awarded but remain unpaid as of the Date of Termination, (iii) any unpaid or unreimbursed
expenses incurred in accordance with Section 6 hereof, (iv) any accrued but unpaid benefits provided under the Company’s
employee benefit plans, subject to and in accordance with the terms of those plans, (v) any accrued but unpaid rights to indemnification
by virtue of the Employee’s position as an officer or director of the Company or its subsidiaries and the benefits under
any directors’ and officers’ liability insurance policy maintained by the Company, in accordance with its terms thereof,
and (vi) any accrued but unused vacation time through the Date of Termination.

 

(c)        
“Annual Equity Grant” shall have the meaning ascribed to in Section 4(c) hereof.

 

(d)       
“Base Salary” shall mean the salary provided for in Section 4(a) hereof.

 

(e)        
“Beneficial Ownership” shall have the meaning set forth in in Rule 13d-3 of the Exchange Act; provided,
however, that, notwithstanding anything in Rule 13d-3 of the Exchange Act to the contrary, for purposes of Section 1(k)(1)
below, a Person shall not be deemed to have Beneficial Ownership of any shares of Common Stock underlying any Common Stock Equivalents
unless and until such Person actually acquires such shares of Common Stock upon exercise, exchange or conversion of such Common
Stock Equivalents.

 

    1

     

    

(f)        
“Board” shall mean the Board of Directors of the Company or any committee thereof.

 

(g)       
“Common Stock” shall mean the Company’s common stock, $0.01 par value per share.

 

(h)       
“Common Stock Equivalents” shall mean any securities of the kind which would entitle the holder thereof to acquire
at any time, Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

(i)         
“Confidentiality Agreement” shall mean the Company’s Confidential Information and Invention Assignment
Agreement attached hereto as Exhibit B.

 

(j)        “Cause”
shall mean (i) Employee’s willful failure (except where due to a physical or mental infirmity or incapacity) or refusal
to perform in any material respect Employee’s duties and responsibilities if and to the extent that such duties and responsibilities
are reasonable and lawful, (ii) any willful or grossly negligent act of Employee that has, or could reasonably be expected
to have, the effect of injuring the business of the Company or its subsidiaries in any material respect; (iii) Employee’s
conviction of, or plea of guilty or no contest to: (x) a felony (other than a felony related to the operation of a motor vehicle),
(y) any material violation of federal or state securities laws or (z) any other criminal charge that has, or could be
reasonably expected to have, a material adverse effect on the performance of Employee’s duties to the Company or otherwise
result in material injury to the business of the Company or its subsidiaries; (iv) the willful commission by Employee of an
act of fraud or embezzlement against the Company or its subsidiaries; (v) any material violation by Employee of the written
policies of the Company or its subsidiaries to the extent provided or made available to Employee, including but not limited to
those relating to sexual harassment or business conduct and those otherwise set forth in the manuals or statements of policy of
the Company or its subsidiaries, which material violation has, or could reasonably be expected to have, the effect of injuring
the business of the Company or its subsidiaries in any material respect, or (vi) Employee’s willful and material breach
of this Agreement or the Confidentiality Agreement. For clarity, the inability of Employee to perform any or all of his duties,
responsibilities or obligations as an employee of the Company or under this Agreement or the Confidentiality Agreement, in each
case on account of Employee’s death or Employee’s physical or mental disability or infirmity, shall not be deemed or
treated as a breach of this Agreement or the Confidentiality Agreement by the Employee and shall not constitute Cause for any purpose
of this Agreement.

 

(k)        “Change
of Control” shall mean the occurrence of any of the following events:

 

(1)       
The acquisition by a Person or its affiliates of ownership of stock of the Company if, immediately after such acquisition, such
Person and its affiliates collectively have Beneficial Ownership of issued and outstanding stock of the Company representing more
than twenty percent (20%) of the total voting power of the issued and outstanding stock of the Company; provided, however, that
for purposes of this subsection (1), the acquisition of stock by a Person from the Company in a transaction or issuance (including
pursuant to equity awards) approved by the Board will not be considered a Change of Control (even if, immediately after such acquisition,
such Person and its affiliates collectively have Beneficial Ownership of issued and outstanding stock of the Company representing
more than twenty percent (20%) of the total voting power of the issued and outstanding stock of the Company, unless at the time
of such acquisition or at any time within one year following such acquisition, the Company’s Executive Chairman is no longer
deemed a Service Provider to the Company and the change in the Executive Chairman’s status was involuntary and not the result
of a termination due to death or disability, in which case such acquisition shall be treated as a Change of Control for purposes
of this subsection (1) notwithstanding that such acquisition or the transaction that resulted in such acquisition was approved
by the Board; or

 

    2

     

    

(2)        If,
during any period of twelve (12) months in which the Company has a class of securities registered pursuant to Section 12 of the
Exchange Act, a change in the composition of the Board occurs as a result of which fewer than a majority of the members of the
Board are Incumbent Directors; or

 

(3)        The
consummation of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would
result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into voting securities of the surviving entity or its parent) at least a majority of the total
voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately
after such merger or consolidation; or

 

(4)        The
acquisition by a Person or its affiliates (or a series of acquisitions by a Person or its affiliates during the twelve (12) month
period ending on the date of the most recent acquisition by such Person or any of its affiliates) of assets from the Company that
have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the
assets of the Company immediately prior to such acquisition or such series of acquisitions; provided, however, that the foregoing
provisions of this subsection (4) shall not be applicable to a transfer of assets by the Company to an entity, fifty percent (50%)
or more of the total value or voting power of which is owned, directly or indirectly, by the Company. For purposes of this subsection
(4), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined
without regard to any liabilities associated with such assets.

 

For the avoidance of doubt, a transaction will
not constitute a Change of Control for purposes of this Section 1(k) if: (i) its primary purpose is to change the jurisdiction
of the Company’s incorporation, or (ii) its primary purpose is to create a holding company that will be owned in substantially
the same proportions by the persons who held the Company’s securities immediately before such transaction.

 

For purposes of this Section, “affiliate”
will mean, with respect to any specified Person, any other Person that directly or indirectly, through one or more intermediaries,
controls, is controlled by, or is under common control with, such specified Person (“control,” “controlled by”
and “under common control with” will mean the possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of a person, whether through ownership of voting securities, by contact or credit arrangement,
as trustee or executor, or otherwise).

 

(l)       “Code”
shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.

 

(m)        “Date
of Termination” shall mean the date on which Employee’s employment as President and Chief Operating Officer of
the Company terminates.

 

(n)        “Dilutive
Event” shall mean, except in the case and to the extent of Common Stock issued upon exercise of Excluded Securities,
the issuance by the Company of Common Stock (i) at any time during the Measurement Period (including, without limitation, by virtue
of the exercise, conversion or exchange of any Qualifying Securities at any time on or prior to the end of the applicable Measurement
Period) or (ii) in connection with the exercise, conversion or exchange of any Qualifying Securities at any time after the Measurement
Period.

 

    3

     

    

(o)        “Disability”
shall mean any physical or mental disability or infirmity of Employee that prevents the performance of Employee’s duties
for a period of (i) ninety (90) consecutive days or (ii) one hundred twenty (120) non-consecutive days during
any twelve (12) month period. Any question as to the existence of the Employee’s Disability as to which the Employee
and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to the Company
and the Employee or, if applicable, Employee’s guardian (which approval shall not be unreasonably withheld). The determination
of Disability made by such physician in writing to the Company and the Employee shall be final and conclusive for all purposes
of this Agreement.

 

(p)        “Effective
Date” shall mean April 1, 2020.

 

(q)       “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(r)        “Excluded
Securities” shall mean stock options exercisable for shares of Common Stock that are granted to officers or employees
(provided that such stock options do not exceed 10% of the Company’s issued and outstanding shares of Common Stock at the
end of the Measurement Period).

 

(s)        “Good
Reason” shall mean, without Employee’s consent, (i)(A) a material diminution in Employee’s duties or
responsibilities (other than temporarily while the Executive is physically or mentally incapacitated or as required by applicable
law), (B) any adverse change in Employee’s title or position, or if Employee ceases to report to the Company’s Chief
Executive Officer, current Executive Chairman or the Board, (C) permanent assignment to Employee of duties not commensurate with
his position, (ii) a reduction in Base Salary other than a general reduction in Base Salary (not to exceed a reduction of
25%) that affects all similarly situated executives in substantially the same proportions, (iii) a reduction in the Target Cash
Bonus opportunity, but nothing herein shall be interpreted to require the Company to pay any Target Cash Bonus, (iv) any requirement
by or directive from the Company that requires Employee to permanently relocate his principal residence or results in a change
in the primary place of the Company’s business by more than 50 miles from its current location, or (v) any other material
breach by the Company of a provision of this Agreement (other than a provision that is covered by any of the foregoing clauses
(i), (ii), (iii), (iv) or (v)) or any other agreement which is directly related to Employee’s employment or which is
specifically referenced in this Agreement. Notwithstanding the foregoing, during the Term, in the event that the Company reasonably
believes that Employee may have engaged in conduct that could constitute Cause hereunder, the Company may, in its sole and absolute
discretion, suspend Employee from performing Employee’s duties hereunder for a period not to exceed 90 days, and in no event
shall such suspension constitute an event pursuant to which Employee may terminate employment with Good Reason or otherwise constitute
a breach hereunder; provided, that no such suspension shall alter the Company’s obligations under this Agreement during
such period of suspension (including, but not limited to, payment of Base Salary as set forth in Section 4(a) hereof).

 

(t)       “Incumbent
Directors” means members of the Board who either (A) are members of the Board as of the date of this Agreement or
(B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent
Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection
with an actual or threatened proxy contest relating to the election of directors to the Company).

 

    4

     

    

(u)       “Inducement
Plan” shall have the meaning ascribed to it in Section 4(d) hereof.

 

(v)       “Measurement
Period” shall mean: (i) the nine (9) month period following the Effective Date, or (ii) in the event that during such
nine (9) month period, the Board authorizes or approves a Dilutive Event or the Company enters into a written agreement that contemplates
effecting a Dilutive Event, then the period of time commencing on the Effective Date and ending upon the occurrence of such Dilutive
Event, whichever is later. Provided however that in the event the Board decides to not consummate the transaction(s) contemplated
in subsection (ii) contained herein, the Measurement Period will be as provided for in subsection (i) contained in this definition.

 

(w)       “Option
Award” shall have the meaning ascribed to it in Section 4(d) hereof.

 

(x)       “Option
Award Adjustment” shall mean, in the event that the Option Award remains outstanding at the time of a Change of Control
transaction (after giving effect to the provisions under the definition of Accelerated Equity Benefit that pertain to the ability
of Employee to exercise any vested outstanding stock options or other equity awards following the last day of the applicable Severance
Term) and that, in connection with such Change of Control transaction, any then outstanding Qualifying Securities are entitled
to receive consideration in connection with such Change of Control transaction or are assumed in connection with such Change of
Control transaction, then, any such Qualifying Securities shall be deemed to be exercised, converted or exchanged in full immediately
prior to the closing of such Change of Control transaction, all of the shares of Common Stock underlying such Qualifying Securities
shall be deemed to be issued immediately prior to the closing of such Change of Control Transaction and such deemed issuance of
such shares of Common Stock shall be deemed to be a Dilutive Transaction that will result in an increase in the number of Option
Shares in accordance with the provisions contemplated in Section 4(d).

 

(y)       “Option
Shares” shall mean the shares of Common Stock underlying the Option Award.

 

(z)       “Payment
Date” shall have the meaning ascribed to it in Section 7(h) hereof.

 

(aa)     “Person” shall mean
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind or more than such person
or entity acting as a group.

 

(bb)     “Post-Dilutive Event Common
Shares” shall mean, with respect to a Dilutive Event, the number of shares of Common Stock issued in connection with
such Dilutive Event plus the number of shares of Qualifying Common Stock outstanding immediately before such Dilutive Event.

 

(cc)     “Pre-Dilutive Event Common Shares”
shall mean, with respect to a Dilutive Event, the number of shares of Qualifying Common Stock outstanding immediately prior to
such Dilutive Event.

 

(dd)     “Qualifying Common Stock”
shall mean (i) shares of Common Stock that are issued and outstanding at any time on or prior to the end of the applicable Measurement
Period (including, without limitation, by virtue of the exercise, conversion or exchange of any Qualifying Securities at any time
on or prior to the end of the applicable Measurement Period), plus (ii) any shares of Common Stock that are issued at any time
after the end of the applicable Measurement Period upon the exercise, conversion or exchange of any Qualifying Securities.

 

    5

     

    

(ee)     “Qualifying Securities”
shall mean any Common Stock Equivalents that are issued and outstanding at any time on or prior to the end of the applicable Measurement
Period.

 

(ff)     “Release of Claims”
shall mean a release of claims made by the Employee in favor of the Company and its subsidiaries in the form attached hereto as
Exhibit A (with any updates reasonably determined by the Company to be necessary to comply with applicable law) and the
execution of which is a condition precedent to Employee’s eligibility for Severance Benefits and the Accelerated Equity Benefit
in the event his employment is terminated by the Company without Cause or by Employee for Good Reason, as described in Sections
7(d) and 7(e), or in connection with a Change of Control, as described in Section 7(g).

 

(gg)     “Severance Benefits”
shall mean (i) continued payment of the Base Salary (as in effect immediately prior to termination of Employee’s employment
with the Company and without giving effect to any proration or any reduction to the Base Salary that gives rise to Good Reason)
during the Severance Term, payable in accordance with the Company’s regular payroll practices, (ii) either (x) a lump sum
payment equal to the product of: (A) Employee’s Target Cash Bonus for the year in which the Termination Date occurs, paid
at a rate equivalent to 100% achievement of objectives for such year and (B) a fraction, the numerator of which is the number of
days the Employee was employed by the Company during the year in which the Date of Termination occurs and the denominator of which
is the number of days in such year, which lump sum payment shall be paid on the Payment Date (as defined in Section 7(h), or (y)
in the event of termination of Employee’s employment with the Company in connection with a Change of Control as described
in Section 7(g), Employee’s Target Cash Bonus for the year in which the Termination Date occurs, paid at a rate equivalent
to 100% achievement of objectives for such year, and (iii) if Employee qualifies for and timely elects continued coverage under
the Company’s group medical plan and/or group dental plan pursuant to Section 4980B of the Code (“COBRA”), monthly
payment during the Severance Term of the amount the Company pays on behalf of comparable employees who have elected the same level
of coverage as Employee.

 

(hh)     “Service Provider”
shall means an employee, director or consultant.

 

(ii)     “Severance Term”
shall mean: (i) in the event the Date of Termination occurs after the 9 month anniversary of the Effective Date, (y) the
eleven (11) month period, which commences on the first day following the Date of Termination by the Company without
Cause or by Employee for Good Reason, or (z) in the event of a Change of Control as described in Section 7(g), the fifteen
(15) month period commencing on the first day following the Date of Termination by the Company without Cause or by Employee
for Good Reason, or (ii) in the event the Date of Termination occurs within 9 months of the Effective Date, (a) the six (6)
month period, which commences on the first day following the Date of Termination by the Company without Cause or by Employee
for Good Reason, or (b) in the event of a Change of Control as described in Section 7(g), the eight (8) month period
commencing on the first day following the Date of Termination by the Company without Cause or by Employee for Good
Reason.

 

(jj)     “Target Cash Bonus”
shall have the meaning ascribed to it in Section 4(b) hereof.

 

(kk)     “Term” shall have
the meaning ascribed to it in Section 2 hereof.

 

Section 2. Acceptance and Term.
Commencing on the Effective Date, the Company agrees to employ Employee on an at-will basis (subject to the terms of Sections
7(b), 7(d), 7(e) and 7(g) hereof), and Employee agrees to accept such employment and serve the Company, in accordance with the
terms and conditions set forth herein. The term of employment shall commence on the Effective Date and continue until terminated
by either party at any time, subject to the provisions herein (referred to herein as the “Term”).

 

    6

     

    

Section 3. Position, Duties, and Responsibilities; Place
of Performance.

 

(a)        Position,
Duties, and Responsibilities. During the Term, Employee shall be employed and serve as President and Chief Operating Officer
of the Company (together with such other position or positions or duties, consistent with Employee’s title or as the Board
may specify on a temporary basis) and shall have such duties and responsibilities commensurate therewith.

 

(b)        Performance.
Employee shall devote his full business time, attention, skill, and best efforts to the performance of his duties under this Agreement
and shall not engage in any other occupation during the Term, including, without limitation, any activity that (x) conflicts
with the interests of the Company, (y) materially interferes with the proper and efficient performance of Employee’s
duties for the Company, or (z) materially interferes with Employee’s exercise of judgment in the Company’s best
interests. Notwithstanding the foregoing, nothing herein shall preclude Employee from: (i) continuing to serve on existing
boards of directors as of the Effective Date until Employee’s current term on those boards expires; (ii) serving, with
the prior consent and approval of the Board (which shall not be unreasonably withheld or delayed), as a member of no more than
two (2) other boards of directors provided that service on any such board complies with the factors contained in (x), (y) and
(z) above or advisory boards (or their equivalents in the case of a non-corporate entity) of non-competing businesses and
charitable organizations; (iii) serving as an officer, director, consultant or advisor of Antidote Therapeutics, Inc. (“Antidote”)
for so long as Antidote continues to conduct business operations in a “virtual-company” mode and thereafter to serve
as a director, consultant or advisor (but not officer) of Antidote, provided that any activities of Employee under this
clause (iii) shall comply with the factors contained in clauses (x), (y) and (z) above in this Section 3(b); (iv) performing his
Professional Activities (as defined below); (v) undertaking other professional activities (subject to the restrictions contained
in clauses (x), (y) and (z) above in this Section 3(b)), with the prior consent and approval of the Board; (vi) engaging in
charitable activities and community affairs; and (vii) managing Employee’s personal investments and affairs; provided,
however, that the activities set out in clauses (i), (ii), (iii), (iv), (v), (vi) and (vii) herein shall be limited
by Employee so as not to interfere in any material respect, individually or in the aggregate, with the performance of Employee’s
duties and responsibilities hereunder, or pose a conflict of interest or violate any provision of this Agreement with such determinations
to be made at the discretion of the Board. Employee represents that he has provided the Company with a comprehensive list of all
outside professional activities with which he is currently involved or reasonably expects to become involved at the current time
(such activities, the “Professional Activities”). In the event that, during his employment by the Company, the Employee
desires to engage in other outside professional activities, not included on such list and permitted under any of the foregoing
clauses (i)-(vii) set forth above in this Section 3(b), Employee will, prior to engaging in any such activities, first seek written
approval from the Board, which approval shall not be unreasonably withheld.

 

Section 4. Compensation.

 

(a)        Base
Salary. In exchange for Employee’s performance of his duties and responsibilities, Employee initially shall be paid an
annual base salary of $415,000 (such annual base salary, as it may be increased from time to time at the sole discretion of the
Board, the “Base Salary”), payable in accordance with the regular payroll practices of the Company but not less
frequently than monthly. The Base Salary shall be reviewed at least annually by the Board and may be increased at the Board’s
sole and absolute discretion. All payments referenced in this Agreement are on a gross, pre-tax basis and shall be subject to all
applicable federal, state and local withholding, payroll and other taxes.

 

    7

     

    

(b)        Target
Cash Bonus. In addition to the Base Salary, Employee will be eligible to earn a discretionary annual target bonus. As of the
Effective Date, Employee’s annual target bonus is up to 45% of his Base Salary, subject to the Board’s discretion to
grant a higher bonus amount (the “Target Cash Bonus”). The Target Cash Bonus amount is subject to annual review
and increase (but not decrease) as determined by the Board. The Target Cash Bonus will be pro-rated for the initial calendar year
of the Term, with such proration calculated based on the number of days Employee is employed by the Company during such year. The
actual amount of Employee’s annual bonus, if any, will be determined by the Board based upon Company performance, its financial
condition, and any other factors that the Board, in its reasonable good faith discretion, deems appropriate after consultation
with Employee. Achievement of such Company performance or any such other factors shall be determined by the Board in its reasonable
good faith discretion. Annual bonuses, if any, shall be paid out no later than March 15 of the year following the applicable
bonus year. Except as otherwise provided in Section 7 of this Agreement, Employee must be employed by the Company at the time
the bonus is awarded and through the end of the calendar year in which any bonus may be earned in order to be eligible for any
such payment.

 

(c)       Annual
Equity Award. In addition to the Base Salary and Target Cash Bonus, Employee will be eligible to receive an annual market-based
equity grant (the “Annual Equity Grant”) issued pursuant to the terms of one of the Company’s equity compensation
plans. The actual amount of such Annual Equity Grant, if any, will be determined by the Board based upon Company performance, its
financial condition (including market value and capitalization), Employee’s achievement of pre-agreed performance milestones
and any other factors that the Board, in its reasonable good faith discretion, deems appropriate. Achievement of such milestones
or any such other factors shall be determined by the Board in its reasonable good faith discretion. In connection with such grants,
the Employee shall enter into one of the Company’s standard equity grant agreements which will incorporate the vesting schedule
and other terms as determined by the Board.

 

(d)        Inducement
Grants. On the Effective Date, as an inducement for Employee’s employment, the Company will grant Employee an option
to purchase 282,840 shares of Common Stock, which option shall be granted under the Company’s Inducement Award Stock Option
Plan (or a successor plan, if any) (the “Inducement Plan”) and shall be subject to the terms and conditions
set forth in this Agreement, the Inducement Plan and a stock option agreement to be entered by the Company and the Employee to
evidence such grant, the form of which has been made available to Employee prior to the Effective Date (the “Option Agreement”
and such grant the “Option Award”). In the event of a conflict between the Option Agreement or the Inducement
Plan, on the one hand, and this Agreement, on the other hand, with respect to the Option Award or any of the terms and conditions
thereof, this Agreement shall control. The option subject to the Option Award shall have a term of ten (10) years from the date
of grant and an exercise price equal to the closing trading price of the Common Stock on the Effective Date (or the prior closing
price if the Effective Date is on a day that the trading markets are not open). The Option Award will be subject to vesting as
follows: (i) 1/4 of the Option Award will vest on the Effective Date, and (ii) the balance of the Option Award will vest monthly
over the following thirty six (36) months; provided, however, that Employee must remain continuously employed through the
applicable vesting dates, and the Option Award shall be subject to accelerated vesting under certain circumstances in accordance
with the provisions of Section 7 hereof. The Option Award shall be subject to the terms set forth in the Option Agreement, the
terms of the Inducement Plan, this Section 4(d), Section 7 hereof, and any other restrictions and limitations generally applicable
to Common Stock of the Company or equity awards held by similarly situated Company executives that are imposed by law. Upon the
occurrence of a Dilutive Event, the Option Shares will be increased by such number as required to make the percentage that the
Option Shares (after giving effect to such increase) represent of the Post-Dilutive Event Common Shares equal to the percentage
that the number of Option Shares immediately prior to the Dilutive Event represent of the Pre-Dilutive Event Common Shares. In
addition, the Option Shares may be increased by the Option Award Adjustment, if applicable, in connection with a Change of Control
transaction. Any increase in the number of Option Shares, as contemplated above in this Section 4(d), in connection with the occurrence
of a Dilutive Event or a Change of Control transaction shall occur automatically pursuant to the terms and conditions of the Option
Award as set forth in this Section 4(d) and the Option Agreement without any act or action required to be taken by either the Company
or Employee.

 

    8

     

    

(e)      Agreement Expense Reimbursement.
The Company agrees to pay Employee’s reasonable legal, accounting and other expenses incurred in connection with the negotiation,
drafting and execution of this Agreement and any agreements ancillary to this Agreement, and any separation arrangements with Employee’s
prior employer, in an amount not to exceed $5,000.

 

(f)       Directors’
and Officers’ Liability Insurance. Employee shall be designated as a “covered person” under the Company’s
Director’s and Officer’s insurance coverage, if any, and shall be covered to the same extent as other directors and
executive officers, including following the termination of Employee’s employment for any reason for the maximum statute of
limitations period which could apply to any claim against Employee which otherwise would be covered by such insurance.

 

(g)      Clawback Provisions. Notwithstanding
any other provisions in this Agreement to the contrary, any incentive-based or other compensation paid to the Employee under this
Agreement or any other agreement or arrangement with the Company which is subject to recovery under any law, government regulation,
or stock exchange listing requirement will be subject to such deductions and clawback as may be required to be made pursuant to
such law, government regulation, or stock exchange listing requirement (or any policy adopted by the Company pursuant to any such
law, government regulation or stock exchange listing requirement).

 

Section 5. Employee Benefits. During
the Term, Employee shall be eligible to participate in health insurance and other benefits provided generally to similarly situated
employees of the Company, subject to the terms and conditions of the applicable benefit plans (which shall govern). In addition
to holidays recognized by the Company, Employee also shall receive four (4) weeks of paid vacation per year, with up to a maximum
of two (2) weeks that can carry over on a yearly basis. Nothing contained herein shall be construed to limit the Company’s
ability to amend, suspend, or terminate any employee benefit plan or policy at any time without providing Employee notice, and
the right to do so is expressly reserved.

 

Section 6.
Reimbursement of Business Expenses. The Company shall pay (or promptly reimburse Employee)
for documented, out-of-pocket expenses reasonably incurred by Employee in the course of performing his duties and responsibilities
hereunder, which are consistent with the Company’s policies in effect and as amended from time to time, with respect to business
expenses, subject to the Company’s requirements with respect to documentation and reporting of such expenses.

 

Section 7. Termination of Employment.

 

(a)        General.
Employee’s employment with the Company shall terminate upon the earliest to occur of: (i) Employee’s death, (ii) a
termination by reason of Employee’s Disability, (iii) a termination by the Company with or without Cause, or (iv) a
termination by Employee with or without Good Reason.

 

(b)        Termination
Due to Death or Disability. Employee’s employment under this Agreement will terminate automatically upon Employee’s
death. The Company also may terminate Employee’s employment immediately upon the occurrence of a Disability, such termination
to be effective upon Employee’s receipt of written notice of such termination. In the event of Employee’s termination
as a result of Employee’s death or Disability, Employee’s or Employee’s estates or beneficiaries, as the case
may be, will be entitled to receive the Accrued Obligations. Employee shall have no further rights to any compensation or any other
benefits under this Agreement.

 

    9

     

    

(c)        Termination by
the Company with Cause.

 

(i)        The
Company may terminate Employee’s employment at any time with Cause, effective upon Employee’s receipt of written notice
of such termination; provided, however, that with respect to any Cause termination relying on clause (i), (ii), (v),
or (vi) of the definition of Cause set forth in this Agreement, to the extent that such act or acts or failure or failures
to act are curable, Employee shall be given thirty (30) days’ written notice by the Company of its intention to terminate
his employment with Cause, such notice to state the act or acts or failure or failures that constitute the grounds on which the
proposed termination with Cause is based, and such termination shall be effective at the expiration of such thirty (30) day
notice period unless Employee has fully cured such act or acts or failure or failures to act, to the Board’s complete satisfaction,
that give rise to Cause during such period.

 

(ii)        In
the event that the Company terminates Employee’s employment with Cause, Employee shall be entitled only to the Accrued Obligations.
Following such termination of Employee’s employment with Cause, except as set forth in this Section 7(c)(ii), Employee
shall have no further rights to any compensation or any other benefits under this Agreement. For the avoidance of doubt, Employee’s
sole and exclusive compensation upon a termination of employment by the Company with Cause shall be receipt of the Accrued Obligations.

 

(d)        Termination
by the Company without Cause. The Company may terminate Employee’s employment at any time without Cause, effective upon
Employee’s receipt of written notice of such termination. In the event that Employee’s employment is terminated by
the Company without Cause (other than due to death or Disability) and, with respect to the Severance Benefits and the Accelerated
Equity Benefits, provided that he fully executes and does not revoke an effective Release of Claims as described in Section 7(h),
then, except as otherwise provided in Section 7(g), Employee shall be entitled to:

 

		(i)	the Accrued Obligations;

 

		(ii)	the Severance Benefits; and

 

		(iii)	the Accelerated Equity Benefit.

 

Notwithstanding the foregoing, the Severance Benefits shall immediately
terminate, and the Company shall have no further obligations to Employee with respect thereto, in the event that Employee is found
by a court of competent jurisdiction to have breached this Agreement, any provision of the Confidentiality Agreement or the Release
of Claims. Any such termination of payment or benefits shall have no effect on the Release of Claims or any of Employee’s
post-employment obligations to the Company. Following such termination of Employee’s employment by the Company without Cause,
except as set forth in this Section 7(d) or 7(g), Employee shall have no further rights to any compensation or any other benefits
under this Agreement. For the avoidance of doubt, except as otherwise provided in Section 7(g), Employee’s sole and
exclusive compensation upon a termination of employment by the Company without Cause shall be receipt of (i) the Severance
Benefits and Accelerated Equity Benefits subject to his execution of the Release of Claims, and (ii) the Accrued Obligations.
If the Company makes overpayments of Severance Benefits, Employee promptly shall return any such overpayments to the Company and/or
hereby authorizes deductions from future Severance Benefit amounts so long as such deduction does not violate Section 409A of the
Code.

 

    10

     

    

(e)        Termination
by Employee with Good Reason. Employee may terminate his employment with Good Reason by providing the Company at least thirty
(30) days’ written notice setting forth in reasonable specificity, the event that constitutes Good Reason, which written
notice, to be effective, must be provided to the Company on or prior to the later of: (i) within thirty (30) days of the occurrence
of such event or (ii) promptly upon Employee’s actual knowledge of such event. During such notice period, the Company shall
have a cure right (if curable), and if not cured within such period, Employee’s termination will be effective upon the expiration
of such cure period, and Employee shall be entitled to the same payments and benefits as provided in Section 7(d) hereof,
subject to the same conditions on payment and benefits as described in Section 7(d) hereof. Following such termination of
Employee’s employment by Employee with Good Reason, except as set forth in this Section 7(e) or as otherwise provided
in Section 7(g), Employee shall have no further rights to any compensation or any other benefits under this Agreement. For
the avoidance of doubt, except as otherwise provided in Section 7(g), Employee’s sole and exclusive compensation upon
a termination of employment with Good Reason shall be receipt of the same payments and benefits described in Section 7(d) hereof,
subject to the same conditions on payment and benefits as described in Section 7(d).

 

(f)        Termination
by Employee without Good Reason. Employee may terminate his employment without Good Reason by providing the Company at least
thirty (30) days’ written notice of such termination. In the event of a termination of employment by Employee under
this Section 7(f), Employee shall be entitled only to the Accrued Obligations. In the event of termination of Employee’s
employment under this Section 7(f), the Company may, in its sole and absolute discretion, by written notice accelerate such
date of termination without changing the characterization of such termination as a termination by Employee without Good Reason.
Following such termination of Employee’s employment by Employee without Good Reason, except as set forth in this Section 7(f)
or as otherwise provided in Section 7(g), Employee shall have no further rights to any compensation or any other benefits
under this Agreement. For the avoidance of doubt, Employee’s sole and exclusive compensation upon a termination of employment
by Employee without Good Reason shall be receipt of the Accrued Obligations.

 

(g)        Termination
in connection with a Change of Control. In the event that Employee’s employment is terminated in the three (3) month
period preceding or the twelve (12) month period following a Change of Control: (a) by the Company for any reason other
than as a result of Employee’s death or Disability pursuant to Section 7(b) or Cause as provided in Section 7(c),
or (b) by Employee with Good Reason pursuant to Section 7(e), then Employee shall be entitled to (in lieu of, and not
in addition to, any payments described in Section 7(d) or (e) of this Agreement):

 

		(i)	the Accrued Obligations;

 

		(ii)	the Severance Benefits; and

 

		(iii)	the Accelerated Equity Benefit.

 

Notwithstanding the foregoing, the Severance Benefits shall immediately
terminate, and the Company shall have no further obligations to Employee with respect thereto, in the event that Employee is found
by a court of competent jurisdiction to have breached this Agreement, any provision of the Confidentiality Agreement or the Release
of Claims. Any such termination of payment or benefits shall have no effect on the Release of Claims or any of Employee’s
post-employment obligations to the Company. If the Company makes overpayments of Severance Benefits, Employee promptly shall return
any such overpayments to the Company and/or hereby authorizes deductions from future Severance Benefit amounts.

 

    11

     

    

(h)        Release.
Notwithstanding any provision herein to the contrary, the payment of the Severance Benefits and the provision of the Accelerated
Equity Benefit, pursuant to subsection (b), (d), (e) or (g) of this Section 7, shall be conditioned upon Employee’s
execution, delivery to the Company, and non-revocation of the Release of Claims (and the expiration of any revocation period contained
in such Release of Claims) in accordance with the time limits set forth therein (and, in all events, within sixty (60) days
following the Date of Termination); provided, that, in the case of Employee’s death or Disability, such actions shall be
taken by a representative with authority to bind Employee or, if applicable, his estate. If Employee or his representative fails
to execute the Release of Claims in such a timely manner, or timely revokes Employee’s acceptance of such release following
its execution, Employee and his estate or beneficiaries shall not be entitled to any of the Severance Benefits or the Accelerated
Equity Benefit. Payment of the Severance Benefits will commence (or, at the election of the Company, may be paid in a lump-sum
cash payment rather than in installments during the Severance Term) on the first regular Company payday that is at least five (5) business
days following the date the Company receives a timely, effective and non-revocable Release of Claims (the “Payment Date”);
provided, however, that the first payment will be retroactive to the day immediately following the Date of Termination. Payment
of the bonus contained in the Severance Benefits defined in Section 1(gg) will also be made on the Payment Date. Notwithstanding
the foregoing, to the extent that any portion of the Severance Benefits or the bonus contained in the Severance Benefits defined
in Section 1(gg) constitutes “non-qualified deferred compensation” subject to Section 409A of the Code, any payment
of such portion scheduled to occur prior to the sixtieth (60th) day following the date of Employee’s termination of
employment hereunder, but for the condition on executing the Release of Claims as set forth herein, shall not be made until the
first regularly scheduled payroll date following such sixtieth (60th) day unless otherwise permitted by Section 409A of the
Code, after which any remaining such benefits shall thereafter be provided to Employee according to the applicable schedule set
forth herein. If the sixty (60) day period following Employee’s separation from service begins in one calendar year and ends
in a second calendar year (a “Crossover 60-Day Period”), and if there are any payments due to Employee that are: (i)
conditioned on Employee signing and not revoking a release of claims and (ii) otherwise due to be paid during the portion of, the
Crossover 60-Day Period that falls within the first year, then such payments will be delayed and paid in a lump sum during the
portion of the Crossover 60-Day Period that falls within the second year.

 

Section 8. Confidentiality Agreement; Cooperation.

 

(a)        Confidentiality
Agreement. As a condition of Employee’s employment with the Company under the terms of this Agreement, Employee has executed
and delivered to the Company a Confidentiality Agreement. The parties hereto acknowledge and agree that this Agreement and the
Confidentiality Agreement shall be considered separate contracts. In addition, Employee represents and warrants that he shall be
able to and will perform the duties of this position without utilizing any confidential and/or proprietary information that Employee
may have obtained in connection with employment with any prior employer, and that he shall not (i) disclose any such information
to the Company, or (ii) induce any Company employee to use any such information, in either case in violation of any confidentiality
obligation, whether by agreement or otherwise.

 

(b)        Litigation
and Regulatory Cooperation. During and after Employee’s employment, Employee shall cooperate fully with the Company in
the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf
of the Company which relate to events or occurrences that transpired while the Company employed Employee, provided, that the Employee
will not have an obligation under this paragraph with respect to any claim in which the Employee has filed directly against the
Company or related persons or entities or if such cooperation would be materially adverse to his own legal interests. The Employee’s
full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel
to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times. During and after
Employee’s employment, Employee also shall cooperate fully with the Company in connection with any investigation or review
of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that transpired
while Employee was employed by the Company, provided Employee will not have any obligation under this paragraph with respect to
any claim in which Employee has filed directly against the Company or related persons or entities. The Company shall reimburse
Employee for any reasonable and documented out-of-pocket expenses incurred in connection with Employee’s performance of obligations
pursuant to this Section 8(b) In the event that Employee has ceased to be employed by the Company prior to the performance
of the obligation pursuant to this Section 10(b), the Company shall compensate Employee at a rate of $250 per hour for all reasonable
documented time.

 

    12

     

    

Section 9. Taxes. 

 

The Company may withhold from any payments
made under this Agreement all applicable taxes, including but not limited to income, employment, and social insurance taxes, as
shall be required by law. Employee acknowledges and represents that the Company has not provided any tax advice to him in connection
with this Agreement and that Employee has been advised by the Company to seek tax advice from Employee’s own tax advisors
regarding this Agreement and payments that may be made to him pursuant to this Agreement, including specifically, the application
of the provisions of Section 409A of the Code to such payments. The Company shall have no liability to Employee or to any
other person if any of the provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A
but that do not satisfy an exemption from, or the conditions of, that section, except in the event of the Company’s or its
subsidiaries’ gross negligence or bad faith.

 

Section 10. Additional Section 409A
Provisions. 

 

Notwithstanding any provision in this Agreement
to the contrary:

 

(a)        If
at the time of the Employee’s separation from service within the meaning of Section 409A of the Code, the Company determines
that the Employee is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to
the extent any payment or benefit that the Employee becomes entitled to under this Agreement on account of the Employee’s
separation from service is “non-qualified deferred compensation” subject to Section 409A of the Code and not otherwise
exempt, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (i) six
months and one day after the Employee’s separation from service, or (ii) the Employee’s death. If any such delayed
cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts
that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the
installments shall be payable in accordance with their original schedule.

 

(b)        Each
payment in a series of payments hereunder shall be deemed to be a separate payment for purposes of Section 409A of the Code.
Neither the Company nor Employee shall have the right to accelerate or defer the delivery of any such payments except to the extent
specifically permitted or required by Section 409A.

 

    13

     

    

(c)        To
the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified
deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement or payment
shall be made by the Company no later than the last day of the taxable year following the taxable year in which such expense was
incurred by Employee, (ii) the right to reimbursement, payment or in-kind benefits shall not be subject to liquidation or
exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement, payment or in-kind benefits provided
during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other
taxable year; provided , that the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement
covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement
is in effect.

 

(d)        To
the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation”
under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Employee’s termination
of employment, then such payments or benefits shall be payable only upon the Employee’s “separation from service.”
The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions
set forth in Treasury Regulation Section 1.409A-1(h).

 

(e)        The
parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in
such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may
be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code
and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost
to either party. While the payments and benefits provided hereunder are intended to be structured in a manner to avoid the implication
of any penalty taxes under Section 409A of the Code, in no event whatsoever shall the Company or any of its subsidiaries be
liable for any additional tax, interest, or penalties that may be imposed on Employee as a result of Section 409A of the Code
or any damages for failing to comply with Section 409A of the Code (other than for withholding obligations or other obligations
applicable to employers, if any, under Section 409A of the Code) , except in the event of the Company’s or its subsidiaries’
gross negligence or bad faith.

 

Section 11. Indemnification. On the Effective Date,
Employee and Company will enter into the Company’s standard Indemnification Agreement.

 

Section 12.Additional Section 280G Provisions. Notwithstanding
any provision in this Agreement to the contrary:

 

(a)        If
any of the payments or benefits received or to be received by Employee (including, without limitation, any payment or benefits
received in connection with a Sale Event, Change of Control, or Employee’s termination of employment, whether pursuant to
the terms of this Agreement or any other plan, arrangement or agreement, or otherwise) (all such payments collectively referred
to herein as the “280G Payments”) constitute “parachute payments” within the meaning of Section 280G of
the Code and would, but for this Section 11(a), be subject to the excise tax imposed under Section 4999 of the Code (the “Excise
Tax”), then prior to making the 280G Payments, a calculation shall be made comparing (i) the Net Benefit (as defined below)
to Employee of the 280G Payments after payment of the Excise Tax to (ii) the Net Benefit to Employee if the 280G Payments are limited
to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under clause (i) above is less
than the amount under clause (ii) above will the 280G Payments be reduced to the minimum extent necessary to ensure that no portion
of the 280G Payments is subject to the Excise Tax. “Net Benefit” shall mean the present value of the 280G Payments
net of all federal, state, local, foreign income, employment, and excise taxes. Any reduction made pursuant to this Section 11(a)
shall be made in a manner determined by the Company that is consistent with the requirements of Section 409A of the Code.

 

    14

     

    

(b)        All
calculations and determinations under this Section 11 shall be made by an independent accounting firm or independent tax counsel
appointed by the Company (the “Tax Counsel”) whose determinations shall be conclusive and binding on the Company and
the Executive for all purposes. The Company shall bear all costs the Tax Counsel may incur in connection with its services.

 

Section 13. Successors and Assigns.

 

(a)        The
Company. Except with respect to an assignment of this Agreement to a successor or affiliated entity, this Agreement may not
be assigned without Employee’s prior written consent.

 

(b)        Employee.
Employee’s rights and obligations under this Agreement shall not be transferable by Employee by assignment or otherwise,
without the prior written consent of the Company; provided, however, that if Employee shall die, all cash amounts
then payable to Employee hereunder shall be paid in accordance with the terms of this Agreement to Employee’s devisee, legatee,
or other designee, or if there be no such designee, to Employee’s estate.

 

Section 14. Waiver and Amendments.
Any waiver, alteration, amendment, or modification of any of the terms of this Agreement shall be valid only if made in writing
and signed by each of the parties hereto; provided, however, that any such waiver, alteration, amendment, or modification
must be consented to on the Company’s behalf by the Board. No waiver by either of the parties hereto of their rights hereunder
shall be deemed to constitute a waiver with respect to any subsequent occurrences or transactions hereunder unless such waiver
specifically states that it is to be construed as a continuing waiver.

 

Section 15. Severability. If
any covenants or such other provisions of this Agreement are found to be invalid or unenforceable by a final determination of a
court of competent jurisdiction, (a) the remaining terms and provisions hereof shall be unimpaired, and (b) the invalid
or unenforceable term or provision hereof shall be deemed replaced by a term or provision that is valid and enforceable and that
comes closest to expressing the intention of the invalid or unenforceable term or provision hereof.

 

Section 16. Governing Law and Jurisdiction.
This is a Maryland contract and shall be construed under and be governed in all respects by the laws of Maryland without giving
effect to the conflict of laws principles of such state. To the extent that any court action is initiated to enforce this Agreement,
the parties hereby consent to the non-exclusive jurisdiction of the state and federal courts of Maryland. Accordingly, with respect
to any such court action, each of the Company and Employee hereby (a) submits to the personal jurisdiction of such courts;
(b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court,
or otherwise) with respect to personal jurisdiction or service of process.

 

Section 17.  Notices. 

 

(a)        Place
of Delivery. Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or
delivered to the party for whom or which it is intended at such address as may from time to time be designated by it in a notice
mailed or delivered (electronic delivery is acceptable) to the other party as herein provided; provided, that unless and
until some other address be so designated, all notices and communications by Employee to the Company shall be mailed or delivered
to the Company at its principal executive office, and all notices and communications by the Company to Employee may be given to
Employee personally or may be mailed to Employee at Employee’s last known address, as reflected in the Company’s records.

 

    15

     

    

(b)        Date
of Delivery. Any notice so addressed shall be deemed to be given or received (i) if delivered by hand, on the date of
such delivery, (ii) if mailed by courier or by overnight mail or electronic mail, on the first business day following the
date of such mailing, and (iii) if mailed by registered or certified mail, on the third business day after the date of such
mailing.

 

Section 18.  Section Headings.
The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to
constitute a part thereof or affect the meaning or interpretation of this Agreement or of any term or provision hereof.

 

Section 19.  Entire Agreement.
This Agreement, together with Release of Claims, Confidentiality Agreement, the Indemnification Agreement, the Inducement Plan,
and any stock option agreement entered into between the Company and Employee thereunder, constitute the entire understanding and
agreement of the parties hereto regarding the employment of Employee. This Agreement supersedes all prior negotiations, discussions,
correspondence, communications, understandings, and agreements between the parties (including without limitation that any term
sheet or offer letter that may have been given to Employee) relating to the subject matter of this Agreement.

 

Section 20.  Survival of Operative
Sections. Upon any termination of Employee’s employment, the provisions of Section 6 through Section 22 of this
Agreement (together with any related definitions set forth in Section 1 hereof) shall survive to the extent necessary to give
effect to the provisions thereof.

 

Section 21.  Counterparts. This
Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together
shall constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.

 

Section 22.  Gender Neutral. Wherever
used herein, a pronoun in the masculine gender shall be considered as including the feminine gender unless the context clearly
indicates otherwise.

 

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

 

 

    16

     

    

[SIGNATURE PAGE TO EMPLOYMENT AGREEMENT]

 

 

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first
above written.

 

 

 

SENECA BIOPHARMA, INC.

 

 

__________________________  

By: 

Title: 

 

 

 

 

 

 

 

EMPLOYEE

 

 

 

_________________________ 

By: 

 

 

 

    17

     

    

EXHIBIT A

 

General Release and Waiver of Claims

 

In exchange for the severance benefits to be
provided to me under the Employment Agreement between me and Seneca Biopharma, Inc. (the “Company”), dated as of April
1, 2020,(the “Employment Agreement”), to which I would not otherwise be entitled, on my own behalf and that of my heirs,
executors, administrators, beneficiaries, personal representatives and assigns, I agree that this General Release and Waiver of
Claims (the “Release of Claims”) shall be in complete and final settlement of any and all causes of action, rights
and claims, whether known or unknown, accrued or unaccrued, contingent or otherwise, that I have had in the past, now have, or
might now have, in any way related to, connected with or arising out of my employment or its termination, under the Employment
Agreement, or pursuant to Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination
in Employment Act, as amended by the Older Workers Benefit Protection Act, the Worker Adjustment and Retraining Notification Act,
the Employee Retirement Income Security Act, the wage and hour, wage payment and fair employment practices laws and statutes of
the State of Maryland (each as amended from time to time), and/or any other federal, state or local law, regulation or other requirement
(collectively, the “ Claims ”), and I hereby release and forever discharge the Company, its subsidiaries and
all of their respective past, present and future directors, shareholders, officers, members, managers, general and limited partners,
employees, employee benefit plans, administrators, trustees, agents, representatives, successors and assigns, and all others connected
with any of them, both individually and in their official capacities, from, and I hereby waive, any and all such Claims. This release
shall not apply to (a) any claims that arise after I sign this Release of Claims, including my right to enforce the terms
of this Release of Claims, the Employment Agreement, the Confidentiality Agreement, the Inducement Plan, the Option Agreement and
any other contract between me and the Company; (b) any claims that may not be waived pursuant to applicable law; (c) any
right to indemnification that I may have under the certificate of incorporation or by-laws of the Company, and any Indemnification
Agreement between me and the Company or any insurance policies maintained by the Company; or (d) any right to receive any
vested benefits under the terms of any employee benefit plans and my award agreements thereunder.

 

Nothing contained in this Release of Claims shall be construed to
prohibit me from filing a charge with or participating in any investigation or proceeding conducted by the federal Equal Employment
Opportunity Commission or a comparable state or local agency, provided, however, that I hereby agree to waive my right to recover
monetary damages or other individual relief in any charge, complaint or lawsuit filed by me or by anyone else on my behalf.

 

In signing this Release of Claims, I acknowledge my understanding
that I may consider the terms of this Release of Claims for up to [twenty-one (21)/forty-five (45)]1 days from the
date I receive it and that I may not sign this Release of Claims until after the date my employment with the Company terminates.
I also acknowledge that I am hereby advised by the Company to seek the advice of an attorney prior to signing this Release of Claims;
that I have had sufficient time to consider this Release of Claims and to consult with an attorney, if I wished to do so, or to
consult with any other person of my choosing before signing; and that I am signing this Release of Claims voluntarily and with
a full understanding of its terms.

  

I further acknowledge that, in signing this Release of Claims, I
have not relied on any promises or representations, express or implied, that are not set forth expressly in the Release of Claims.
I understand that I may revoke this Release of Claims at any time within seven (7) days of the date of my signing by written
notice to the Chairman of the Company’s Board of Directors and that this Release of Claims will take effect only upon the
expiration of such seven-day revocation period and only if I have not timely revoked it.

 

 

_________________________

1 To be determined by the Company at the time of termination.

 

    18

     

    

Intending to be legally bound, I have signed this Release of Claims as of the date written
below.

 

 

 

Signature ___________________________

 

Name ______________________________

 

Date Signed _________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    19

     

    

EXHIBIT B

 

Confidential Information and Invention Assignment Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]